AstraZeneca’s $545m Deal with Pinetree for EGFR Degrader

Georgio Naffaa
Tagged:

Gowling WLG advised AstraZeneca on exclusive option and global license agreement with Pinetree Therapeutics.AstraZeneca has entered into an exclusive option and global license agreement with the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here